ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cashflow Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹156 Cr | ₹220 Cr | ₹134 Cr | ₹83 Cr | ₹127 Cr |
| Adjustment | ₹76 Cr | ₹-7.07 Cr | ₹-4.80 Cr | ₹9.66 Cr | ₹14 Cr |
| Changes In working Capital | ₹-103 Cr | ₹-128 Cr | ₹-30 Cr | ₹33 Cr | ₹-3.95 Cr |
| Cash Flow after changes in Working Capital | ₹130 Cr | ₹84 Cr | ₹99 Cr | ₹126 Cr | ₹137 Cr |
| Cash Flow from Operating Activities | ₹65 Cr | ₹28 Cr | ₹58 Cr | ₹101 Cr | ₹105 Cr |
| Cash Flow from Investing Activities | ₹31 Cr | ₹22 Cr | ₹18 Cr | ₹4.74 Cr | ₹173 Cr |
| Cash Flow from Financing Activities | ₹-66 Cr | ₹-44 Cr | ₹-24 Cr | ₹-9.46 Cr | ₹-8.97 Cr |
| Net Cash Inflow / Outflow | ₹31 Cr | ₹5.23 Cr | ₹52 Cr | ₹96 Cr | ₹269 Cr |
| Opening Cash & Cash Equivalents | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr | ₹84 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹536 Cr | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr |
Compare Cashflow Statement of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹22,887.8 Cr | 0.8% | 0.2% | 25.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 0.8% |
0.2% |
25.8% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses